Detalles de la búsqueda
1.
Subcutaneous Levodopa Infusion for Parkinson's Disease: 1-Year Data from the Open-Label BeyoND Study.
Mov Disord
; 36(11): 2687-2692, 2021 11.
Artículo
en Inglés
| MEDLINE | ID: mdl-34496081
2.
Bioequivalence of cyclobenzaprine hydrochloride extended-release capsule taken intact or sprinkled over applesauceâ©.
Int J Clin Pharmacol Ther
; 55(12): 931-938, 2017 Dec.
Artículo
en Inglés
| MEDLINE | ID: mdl-29092731
3.
A Phase III Study of Balugrastim Versus Pegfilgrastim in Breast Cancer Patients Receiving Chemotherapy With Doxorubicin and Docetaxel.
Oncologist
; 21(1): 7-15, 2016 Jan.
Artículo
en Inglés
| MEDLINE | ID: mdl-26668251
4.
Safety and efficacy of continuous subcutaneous levodopa-carbidopa infusion (ND0612) for Parkinson's disease with motor fluctuations (BouNDless): a phase 3, randomised, double-blind, double-dummy, multicentre trial.
Lancet Neurol
; 23(5): 465-476, 2024 May.
Artículo
en Inglés
| MEDLINE | ID: mdl-38499015
5.
Phenytoin Metabolic Ratio, a Marker of CYP2C9 Activity, is Superior to the CYP2C9 Genotype as a Predictor of (S)-Warfarin Clearance.
Clin Pharmacokinet
; 61(8): 1187-1198, 2022 08.
Artículo
en Inglés
| MEDLINE | ID: mdl-35699912
6.
The pharmacokinetics of continuous subcutaneous levodopa/carbidopa infusion: Findings from the ND0612 clinical development program.
Front Neurol
; 13: 1036068, 2022.
Artículo
en Inglés
| MEDLINE | ID: mdl-36438968
7.
ND0612 (levodopa/carbidopa for subcutaneous infusion) in patients with Parkinson's disease and motor response fluctuations: A randomized, placebo-controlled phase 2 study.
Parkinsonism Relat Disord
; 91: 139-145, 2021 10.
Artículo
en Inglés
| MEDLINE | ID: mdl-34619438
8.
Continuous Subcutaneous Levodopa Delivery for Parkinson's Disease: A Randomized Study.
J Parkinsons Dis
; 11(1): 177-186, 2021.
Artículo
en Inglés
| MEDLINE | ID: mdl-33164945
9.
ND0701, A Novel Formulation of Apomorphine for Subcutaneous Infusion, in Comparison to a Commercial Apomorphine Formulation: 28-Day Pharmacokinetic Study in Minipigs and a Phase I Study in Healthy Volunteers to Assess the Safety, Tolerability, Pharmacokinetics and Relative Bioavailability.
CNS Drugs
; 32(5): 443-454, 2018 05.
Artículo
en Inglés
| MEDLINE | ID: mdl-29637529
10.
A thorough QT study to assess the effects of tbo-filgrastim on cardiac repolarization in healthy subjects.
Drug Des Devel Ther
; 9: 2653-62, 2015.
Artículo
en Inglés
| MEDLINE | ID: mdl-26028962
11.
First-in-human, phase I/IIa dose-escalation and safety study of balugrastim in breast cancer patients receiving myelosuppressive chemotherapy.
Cancer Chemother Pharmacol
; 75(5): 929-39, 2015 May.
Artículo
en Inglés
| MEDLINE | ID: mdl-25740691
12.
Phase II dose-finding study of balugrastim in breast cancer patients receiving myelosuppressive chemotherapy.
Med Oncol
; 32(6): 623, 2015 Jun.
Artículo
en Inglés
| MEDLINE | ID: mdl-25966791
13.
Efficacy and safety of balugrastim compared with pegfilgrastim in patients with breast cancer receiving chemotherapy.
Clin Breast Cancer
; 14(2): 101-8, 2014 Apr.
Artículo
en Inglés
| MEDLINE | ID: mdl-24485296
14.
Clinical pharmacology tyramine challenge study to determine the selectivity of the monoamine oxidase type B (MAO-B) inhibitor rasagiline.
J Clin Pharmacol
; 50(12): 1420-8, 2010 Dec.
Artículo
en Inglés
| MEDLINE | ID: mdl-20445015
15.
Effects of folic acid supplementation on the pharmacokinetics and anticoagulant effect of warfarin: an open-label, prospective study of long-term administration in adults.
Clin Ther
; 32(2): 347-56, 2010 Feb.
Artículo
en Inglés
| MEDLINE | ID: mdl-20206792
Resultados
1 -
15
de 15
1
Próxima >
>>